Anthony (Tony) joined Pennside in 2008 and has over 25 years of pharmaceutical industry experience including 20+ years at GlaxoSmithKline. He began his career at as a bench scientist and is a trained biochemist/molecular pharmacologist. Tony brings a wide range of competitive intelligence experience to Pennside, with specialization in the areas of orphan diseases, immunology/dermatology, cardiovascular, oncology and vaccines. His drug development experience includes work on COREG®, TVEVETEN® and TYKERB®. Tony holds 5 US Patents in novel gene discovery and is an author on more than 50 peer-reviewed publications and medical conference abstracts.